WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Monday, August 29, 2016

Aussie medtech company Global Kinetics appoints US CEO

Aug 30,  2016

Global Kinetics has appointed a new CEO, US medtech veteran Tim Still.



Australian medical technology company Global Kinetics, which makes a smart watch-style device to help treat patients with Parkinson's disease, has appointed a new chief executive from San Francisco as part of its strategy to help drive the company's US growth.
The leadership change for the business, which makes a device called the Parkinson's KinetiGraph (PKG) that looks like a smart watch but actually records specific movement data of Parkinson's sufferers, comes after it raised $14.8 million last year from a range of investors including Brandon Capital Partners, in order to enter the US market.
The company has appointed Tim Still to the helm. Mr Still has 26 years' experience in the health technology sector at companies such as diagnostics technology companies Xagenic and Accumetrics.
"Andrew Maxell [the former chief executive] was the right person to build the company to this point and he got technology out to some of the new markets, but I was brought in basically to take it to the next level and to help drive it from the standpoint of getting reimbursements in key markets like here in the US," he said.
"Right now we're fortunate because we're dealing with an awful lot of priorities and there's interest from a variety of partners, including larger medical device and pharmaceutical companies, so in the next few months it's going to be about prioritising our opportunities."


Global Kinetics is now in 17 countries and more than 10,000 people are using its Parkinson's treatment device in about 200 movement disorder clinics globally.
The PKG not only monitors patients' movements, but reminds them when to take their medication, giving clinicians a more accurate picture of the person's dyskinesia and how it changes throughout the day. This leads to changes in how the neurologist manages a person's symptoms.
Despite having a new US-based leader, the company has no plans to shift its headquarters from Australia.
"Australia gives us a great environment for medical innovation and it's where the technology is developed and manufactured," he said.
"We see ourselves as a global business with offices in Melbourne, Stockholm, Minneapolis and San Francisco. My base in the Bay area will mean we'll have more access to Silicon Valley and we'll be closer to venture capital."
Early next year Global Kinetics will look to do another major capital raising, but Mr Still said no decisions had been made whether it would target Australian or US venture capital firms. A listing is also on the cards f further down the track.
But for the next few months Mr Still said the company was focused on running clinical trials in order to achieve "reimbursements" from the US health insurance companies.
The business will also look to develop the PKG to treat other diseases such as Huntington's, Alzheimer's and epilepsy. 
"That is a longer term goal," Mr Still said. "In the shorter term there is a web of opportunity just with Parkinson's. We're doubling the PKG numbers in the market every year, so there is growth there and we just need to sort through the potential business development partnerships."

http://www.afr.com/technology/aussie-medtech-company-global-kinetics-appoints-us-ceo-20160824-gr0c3l

No comments:

Post a Comment